Compliance & Quality

Stix Enterprises follows Current Good Manufacturing Practice (cGMP) guidance across all of our botanical processing operations. While formal third-party cGMP certification is currently in progress, our facilities and processes are designed and operated in accordance with cGMP principles to ensure product safety, consistency, identity, strength, and purity.

We are actively working toward formal cGMP certification and will update our documentation as milestones are achieved. Customers requiring cGMP certification documentation for their regulatory submissions are encouraged to contact us directly to discuss their specific needs.

Hemp-derived cannabinoid ingredients are regulated at the federal level under the Agriculture Improvement Act of 2018 (2018 Farm Bill). All products sourced and processed by Stix Enterprises are derived from hemp containing less than 0.3% Delta-9 THC on a dry weight basis, in compliance with federal law.

State and local regulations governing hemp-derived cannabinoid ingredients vary significantly. We strongly recommend that customers consult with their own regulatory and legal counsel to ensure compliance with all applicable state and local requirements for their specific use cases, product categories, and markets.

Every product batch supplied by Stix Enterprises is accompanied by a Certificate of Analysis (COA) from an accredited, independent third-party laboratory. COAs verify cannabinoid potency profiles, confirm Delta-9 THC compliance, and screen for heavy metals, residual solvents, pesticides, and microbial contaminants.

Current COAs for each product are available for download below. Batch-specific COAs are provided with every order. For COA requests outside of the documents listed, please contact us directly.